So what are the concerns that are currently uppermost in discusions in the board rooms of the life sciences sector?
Nuclear energy is seen by its supporters as the only real solution for the decarbonisation of the energy sector.
As well as preparing for all the different potential Brexit outcomes, including the move of the European Medicines Agency from London to Amsterdam, the European pharma sector is also facing the implementation of the EU Falsified Medicine Directive within the next few months.
Early summer 2018 has been a time of celebration for anyone involved in chemicals management, particularly the EU REACH regulation.
In less than a year, the UK will leave the EU – the countdown has begun, or has it? What exactly will happen on 29 March 2019?
After many years spent looking enviously across the Atlantic at the funding available to US biotech start-ups from eager venture capitalists, has the UK biotech sector finally entered a ‘golden era’?
2017 has been a year of change. SCI itself has undergone some major changes, from the development of a new website – going live next year – to the introduction of our Bright SCIdea Challenge to encourage entrepreneurship in students.